Ravi Teja’s latest cinematic outing, Irumudi, has strongly resonated with viewers. Ever since its debut week, the emotional action drama—starring the actor widely known as Mass Maharaja—has drawn immense crowds. Beyond cementing a significant milestone for its lead star, the feature has emerged as one of the most lucrative Telugu releases in recent memory and has now claimed the crown of 2026’s most-watched Telugu film in theaters.
Most-Watched Telugu Film Of 2026 In Theaters
As its theatrical run nears its conclusion, the Telugu drama has set multiple benchmarks. It officially stands as the top-viewed Tollywood theatrical release of the year, drawing a cumulative footfall of 1.45 crore since hitting the big screen on August 21. By reaching this milestone, it surpassed Ram Charan’s Peddi and Chiranjeevi’s Mana Shankara Vara Prasad.
Budget & Recovery
Produced on a modest budget of 35 crore, Irumudi has pulled in a staggering domestic net of 184.20 crore over a 26-day span. Generating 149.2 crore in pure net profit above its production costs, the movie yields an extraordinary return on investment of 426.3%, firmly securing a super-hit status.
Trending
Ravi Teja’s picture ranks as the second-most profitable Telugu film of 2026, trailing only Couple Friendly. Overall, it has outpaced the profit margins of nearly every Tollywood release across 2025 and 2026, with just three exceptions: Couple Friendly (2026) alongside Little Hearts and Raju Weds Rambai (both 2025).
More About The Film
Written and directed by Shiva Nirvana, Irumudi was backed by producers Naveen Yerneni and Y Ravi Shankar under the banner of Mythri Movie Makers. The supporting cast features Priya Bhavani Shankar, Sai Kumar, and Baby Nakshathra in pivotal roles.
Irumudi Box Office Summary
- Budget: 35 crore
- India Net: 184.2 crore
- India Gross: 217.36 crore
- Overseas: 22.45 crore
- Worldwide Gross: 239.81 crore
Stay tuned to Koimoi for more box office updates!
Must Read: Sardar 2 Box Office Collection Day 6: To Wrap Up As Karthi’s 2nd Lowest Grosser Post-COVID
Follow Us: Facebook | Instagram | Twitter | YouTube | Google News
